Costantine Albany, MD
Indiana University · Indiana University School of Medicine, Indiana University Simon Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Costantine Albany, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03960151 · Rolapitant Plus Olanzapine in Multiday Cisplatin ChemotherapyCostantine Albany · withdrawn · Germ Cell Tumor · principal investigator
- Ph2NCT02689219 · Brentuximab Vedotin in Relapsed/Refractory Germ Cell TumorsNabil Adra · terminated · Germ Cell Tumors, Testis Cancer, Testicular Cancer · principal investigator
- N/ANCT02677727 · Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell TumorCostantine Albany · completed · Testicular Germ Cell Tumor · principal investigator
- N/ANCT02492360 · Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral NeuropathyCostantine Albany · withdrawn · Peripheral Nervous System Diseases, Testicular Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.